Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising...
News
DLH Wins Follow-On Contract for CMOP Medical Logistics for the Department of Veterans Affairs
Five Year Value of $202 MillionATLANTA, April 23, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the...
Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
REDWOOD CITY, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS) has received notice from immuno-oncology partner...
Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021
TORONTO, April 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will...
Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of the Board of Directors
- Edward J. Sitar appointed as Lead Independent Director of the Board - - Company establishes Science and Technology Committee...
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant...
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
Company to conduct additional clinical study to support submission of a Biologics License Application for TARA-002 in Lymphatic MalformationsNEW YORK,...
CHMP recommends EU approval of Roche’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
If approved, ENSPRYNG will be the first and only treatment available to both adults and adolescents from 12 years of...
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives...
Accolade to Acquire PlushCare
Accolade to begin providing primary care Accolade announces intent to acquire San Francisco-based PlushCare, leading provider of virtual primary care....
CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting
Renowned transplant clinicians to present 15 heart abstracts at ISHLTSOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- CareDx,...
EDAP Announces Pricing of Follow-On Offering
LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies,...
Vistin Pharma ASA: Annual Report for 2020
Oslo, Norway, 23 April 2021 Please find attached the Annual Report for 2020 for Vistin Pharma ASA. There are no...
Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
LONDON and RALEIGH, N.C., April 23, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical...
Notice of Saniona AB annual shareholders’ meeting
PRESS RELEASE April 23, 2021 The English text is an unofficial translation. In case of any discrepancies between the Swedish...
Nicox’s NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment
Press ReleaseNicox’s NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment102 patients randomized as of April 22, 2021, out...
Vistin Pharma ASA: First quarter 2021 financial results
Oslo, Norway, 23rd of April 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the...
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely active ulcerative colitis Mechelen, Belgium;...
Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
About 90,000 women globally die from endometrial cancer each year1VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in...
Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical...